Last reviewed · How we verify

NCT05990673: DRINK

Dose of Remi in Children

Status unknown NA Last updated 14 August 2023
What this trial tests

NA trial testing Remimazolam in Anesthesia in 25 participants. Status unknown.

Timeline
10 August 2023
Primary endpoint
10 September 2023
10 September 2023

Quick facts

Lead sponsorZhihong LU
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsequential
Maskingnone
Primary purposetreatment
Enrollment25
Start date10 August 2023
Primary completion10 September 2023
Estimated completion10 September 2023

Drugs / interventions tested

Conditions studied

Sponsor

Zhihong LU — full company profile →

Who can join

Adults 3 to 12, any sex, with Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Remimazolam has demonstrated the potential as a valuable medication for procedural sedation and general anesthesia. However, the effective dosage of remimazolam in pediatric patients is still unknown.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Remimazolam as a Novel Anesthetic in Pediatric Procedural Sedation and Anesthesia: A Narrative Review.
    Zhu M, Tang M. · · 2025 · cited 1× · PMID 40688881 · DOI 10.7759/cureus.86354

Verify or expand the search:

Other trials of Remimazolam

Trials testing the same drug.

Other recruiting trials for Anesthesia

Currently open trials in the same condition.

Other Zhihong LU trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05990673.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing